Skin ulceration potential of paclitaxel
โ
Robert T. Dorr; Kristi Snead; James D. Liddil
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 454 KB
๐ 2 views
## BACKGROUND. The antimitotic agent paclitaxel is highly active in the therapy of several tumor types, including ovarian and breast cancer. The commercial formulation (TaxoP) is supplied in a vehicle containing alcohol and the surfactant Cremophor EL@ (polyethoxylated castor oil). Whereas Phase I